Crossmark

A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin

Crossref DOI link: https://doi.org/10.1186/s12885-019-5469-8

Published Online: 2019-03-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Forslund, Ola

Sugiyama, Natsuki

Wu, Chengjun

Ravi, Naveen

Jin, Yuesheng

Swoboda, Sabine

Andersson, Fredrik

Bzhalava, Davit

Hultin, Emilie

Paulsson, Kajsa

Dillner, Joakim

Schwartz, Stefan

Wennerberg, Johan

Ekblad, Lars https://orcid.org/0000-0003-0152-786X
Funding

Funding for this research was provided by:

Vetenskapsrådet (VR2015-02388)

Cancerfonden (CAN2015/519)

Laryngfonden

Fru Berta Kamprads Stiftelse

Stiftelsen Konung Gustaf V:s Jubileumsfond

Kung Gustaf V jubileumsfond

SUS stiftelser och donationer

Gunnar Nilssons Cancerstiftelse

Governmental funding of clinical research within the National Health System
License Information

Text and Data Mining valid from 2019-03-25
More Information

Article History

Received: 4 April 2018

Accepted: 13 March 2019

First Online: 25 March 2019

Ethics approval and consent to participate

: The study was approved by Lund University regional ethical review board (LU 376–01), and the samples were collected, after a written informed consent was obtained, at Skåne University Hospital, Lund, Sweden.Experiments on mice were approved by the local ethics committee (488/2017).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.